A myasthenic syndrome associated with combined autoantibodies to postsynaptic acetylcholine receptors and presynaptic voltage-gated calcium channels.
Moschner
C
C
Department of Neurology, Medical University of Lübeck, Germany. moschner_c@neuro.mu-luebeck.de
Moser
A
A
Kömpf
D
D
D000368:Aged; D001323:Autoantibodies / Q000276:immunology*; D015220:Calcium Channels / Q000276:immunology*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008482:Mediastinum / Q000000981:diagnostic imaging; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000276:immunology*; D017981:Receptors, Neurotransmitter / Q000276:immunology*; D013577:Syndrome; D014057:Tomography, X-Ray Computed
D001323:Autoantibodies; D015220:Calcium Channels; D002800:Cholinesterase Inhibitors; D011950:Receptors, Cholinergic; D017981:Receptors, Neurotransmitter; D011729:Pyridostigmine Bromide